Nyxoah is trading at $0.87, 5.54% up; no new company-specific announcement explaining the October 23 move was identified.

  • The latest company news was its October 19 preliminary Q3 update and lowered 2026 revenue outlook.
  • Healthcare rose 1.35% during the regular session, while broad U.S. indices were lower.
  • Available information does not establish that sector strength directly caused Nyxoah’s gain.